infliximab

Search results

Scope

Title Contents All

Date

Bio & Pharma Celltrion’s Remsima SC praised in Europe as preferred biosimilar

MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...

Jun 02, 2023 (Gmt+09:00)

Cookies on KED Global

We use cookies to provide the best user experience. By continuing to browse this website, you will be considered to accept cookies. Please review our Privacy Policy to learn our cookie policy.

Cookies on KED Global Sites

THE KOREA ECONOMIC DAILY, GLOBAL EDITION

SIGN IN
JOIN

Companies
Korean Investors
- Korean Investors Home
- Best Asset Managers by Korean Investors
Deals
- M&A
- ECM/DCM
Markets
Culture & Trends
Perspectives
Hidden Champions
Future Unicorns

Follow us

infliximab

Cookies on KED Global

No articles were found.Please search again.

No articles were found.
Please search again.